EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Comparative Efficacy and Safety of Oral Tranexamic Acid, 1% Arbutin Cream, and Their Combination in the Treatment of Melasma in Sulaymaniyah City: A Randomized Controlled Trial

Hanaa Hama-Rashid

Journal of Sulaimani Medical College · 21.06.2026 · 16 (1)

DOI: 10.17656/jsmc.10496 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Sulaimani Medical College, online erschienen am 21.06.2026. Verfasst von Hanaa Hama-Rashid.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Melasma is a prevalent acquired pigmentary disorder, often affecting women with Fitzpatrick skin types III-VI. Despite various treatment modalities, achieving complete resolution remains challenging due to frequent recurrences. This study evaluates the efficacy and safety of oral tranexamic acid (TXA), topical 1% arbutin cream, and their combination, addressing gaps in long-term therapeutic strategies. Patients and Methods: This open-label RCT, conducted at the Shahid Jabar Dermatology Center in Sulaymaniyah (Dec 2024–Jun 2025), included 120 melasma patients. They were randomized into three groups: Group A (oral TXA), Group B (topical 1% arbutin), and Group C (both). Melasma severity was assessed at baseline, 1, 2, and 3 months. Patient satisfaction was measured with a 5-point Likert scale, and adverse effects were monitored. Follow-up lasted 3 months after treatment discontinuation.

Results

Baseline mMASI scores were similar across groups. After 3 months, Group C showed the greatest reduction (4.25 ± 2.13), followed by Group A (5.70 ± 3.15) and Group B (5.96 ± 2.99). Group C had the highest patient satisfaction (42.5%) and the lowest recurrence rate (14%). Adverse effects were minimal: epigastric pain in Groups A (20%) and C (17.5%), and skin irritation in Group B (2.5%). Group C also demonstrated significantly better outcomes compared to Group B (P = 0.007).

Conclusion

Combination therapy with oral TXA and topical arbutin showed greater efficacy, higher satisfaction, and lower recurrence rates than monotherapy, providing a more durable solution for melasma. Further research is needed to optimize long-term outcomes.

Zitieren

APA

Hama-Rashid, H. (2026). Comparative Efficacy and Safety of Oral Tranexamic Acid, 1% Arbutin Cream, and Their Combination in the Treatment of Melasma in Sulaymaniyah City: A Randomized Controlled Trial. Journal of Sulaimani Medical College, 16(1). https://doi.org/10.17656/jsmc.10496

Vancouver

Hama-Rashid H. Comparative Efficacy and Safety of Oral Tranexamic Acid, 1% Arbutin Cream, and Their Combination in the Treatment of Melasma in Sulaymaniyah City: A Randomized Controlled Trial. Journal of Sulaimani Medical College. 2026;16(1). doi:10.17656/jsmc.10496

BibTeX
@article{HamaRashid2026,
  author = {Hama-Rashid, Hanaa},
  title = {Comparative Efficacy and Safety of Oral Tranexamic Acid, 1% Arbutin Cream, and Their Combination in the Treatment of Melasma in Sulaymaniyah City: A Randomized Controlled Trial},
  journal = {Journal of Sulaimani Medical College},
  year = {2026},
  volume = {16},
  number = {1},
  doi = {10.17656/jsmc.10496}
}
Kostenlos starten →